IMGN Financial Facts

Net loss: -21.62M
License and milestone fees: 5.08M
See Full Income Statement

Total assets: 133.8M
Total current liabilities: 22.81M
See Full Balance Sheet

Immunogen Inc. (IMGN) Earnings

  |   Expand Research on IMGN
Next EPS Date 10/26/15 *Est. EPS Growth Rate +14.5% *Last Qtr.
Average EPS % Beat Rate +59.9% Revenue Growth Rate +119.7% *Last Qtr.
Average % Move 1-Wk after EPS +0.5% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/31/15 Q415 -$0.71-$0.35 -$0.36$12.61M$15.42M N/A Details
4/24/15 Q315 -$0.25-$0.24 -$0.01$11.4M$20.95M N/A Details
1/30/15 Q215 $0.16-$0.05 +$0.21$48.3M$37.3M N/A Details
10/24/14 Q115 -$0.26-$0.15 -$0.11$13.2M$21.8M N/A Details
8/1/14 Q414 -$0.83-$0.32 -$0.51$5.74M$9.72M N/A Details
4/25/14 Q314 -$0.44-$0.27 -$0.17$6.9M$13.28M = Details
1/31/14 Q214 $0.04-$0.18 +$0.22$30.1M$18.16M = Details
10/25/13 Q114 -$0.13-$0.23 +$0.10$17.2M$12.1M = Details